Table 2.
Clinical characteristics by CT/GC positivity among women living with HIV in Brazil, 2015 (N = 802).
| Variable | Total | CT/GC+ | CT/GC− | OR (95% CI) |
|---|---|---|---|---|
| N (%) | N (%) | N (%) | p value | |
| Previous STI | ||||
| Yes | 377 (47.0) | 10 (2.7) | 367 (97.3) | 0.9 (0.40–2.20) |
| No | 425 (53.0) | 12 (2.8) | 413 (97.2) | 1 |
| Previous miscarriage | ||||
| Yes | 171 (21.3) | 5 (2.9) | 166 (97.1) | 1.1 (0.40–2.99) |
| No | 631 (78.7) | 17 (2.7) | 614 (97.3) | 1 |
| Pelvic pain | ||||
| Yes | 137 (17.1) | 6 (4.4) | 131 (95.6) | 1.9 (0.71–4.83) |
| No | 665 (82.9) | 16 (2.4) | 649 (97.6) | 1 |
| Cervical discharge | ||||
| Yes | 212 (26.4) | 12 (5.7) | 200 (94.3) | 3.5 (1.48–8.20) |
| No | 590 (73.6) | 10 (1.7) | 580 (98.3) | 1 |
| Cystitis | ||||
| Yes | 116 (14.5) | 4 (3.4) | 112 (96.6) | 1.3 (0.44–3.98) |
| No | 686 (85.5) | 18 (2.6) | 668 (97.4) | 1 |
| Genital ulcer | ||||
| Yes | 52 (6.5) | 1 (1.9) | 51 (98.1) | 1.5 (0.19–11/14) |
| No | 750 (93.5) | 21 (2.8) | 729 (97.2) | 1 |
| Genital Lymphadenopathy | ||||
| Yes | 26 (3.2) | 2 (7.7) | 24 (92.3) | 3.2 (0.70–14.29) |
| No | 776 (96.8) | 20 (2.6) | 756 (97.4) | 1 |
| Genital Itching | ||||
| Yes | 142 (17.7) | 7 (4.9) | 135 (95.1) | 2.2 (0.89–5.59) |
| No | 660 (82.3) | 15 (2.3) | 645 (97.7) | 1 |
| TARV use | ||||
| Yes | 718 (89.5) | 20 (2.8) | 698 (97.2) | 0.9 (0.20–3.70) |
| No | 84 (10.5) | 2 (2.4) | 82 (97.6) | 1 |
| CD4 Count | ||||
| ≥500 | 508 (63.3) | 15 (3.0) | 493 (97.0) | 0.8 (0.32–1.99) |
| ≤499 | 294 (36.7) | 7 (2.4) | 287 (97.6) | 1 |
| Papanicolau smear | ||||
| Abnormal | 71 (8.9) | 7 (9.9) | 64 (90.1) | 5.2 (2.05–13.27) |
| Normal | 731 (91.1) | 15 (2.1) | 716 (97.9) | 1 |
| Viral load | ||||
| Detectable | 212 (26.4) | 10 (4.7) | 202 (95.3) | 2.3 (1.01–5.60) |
| Undetectable | 590 (73.6) | 12 (2.0) | 578 (98.0) | 1 |